Introduction to Benefit-Risk Assessment - a podcast by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry
from 2019-03-18T23:01
::
::
Benefit-risk assessments are made by various stakeholders including sponsors, regulators, payers, physicians, and patients throughout the life-cycle of a treatment.
The understanding of data plays a vital role in weighting positive and negative effects of medications.
In this episode, we give you an introduction to what benefit-risk (BR) assessment is in order for you to understand your role.
Further episodes of The Effective Statistician - in association with PSI
Further podcasts by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry